3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Thoracic Diseases
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Peritoneal Diseases
1
Paraproteinemias
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Nervous System Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Leiomyosarcoma
1
Immunoglobulin Light-chain Amyloidosis
1
Gigantism
1
Interventions
Sorafenib
20
lenvatinib
18
Hepatectomy
17
Blood Specimen Collection
12
Immune Checkpoint Inhibitors
11
atezolizumab
9
Liver Transplantation
9
Surgical Procedures, Operative
7
Radiofrequency Ablation
7
Observation
7
Bevacizumab
7
regorafenib
5
gadolinium ethoxybenzyl DTPA
5
sintilimab
4
donafenib
4
camrelizumab
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
tislelizumab
3
spartalizumab
3
Polymerase Chain Reaction
3
Neoadjuvant Therapy
3
Mass Spectrometry
3
Immunohistochemistry
3
Doxorubicin
3
Angiogenesis Inhibitors
3
toripalimab
2
pembrolizumab
2
entecavir
2
apatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Hepatocellular
×
Tissue Banks
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled